Georgetown University School of Nursing and Health Studies

New CDAHK Study Finds Severe Adverse Events Associated with Chiropractic Treatment Are Very Rare

Retrieved on: 
Friday, January 27, 2023
Linda, Spine, Data, Bone fracture, Osteoporosis, Scientific Reports, School, Death, Metropolitan University, Safety, University Hospitals Cleveland Medical Center, Risk, Common Terminology Criteria for Adverse Events, Neck pain, Woman, CTCAE, Joint, Patient, Engineering, Roger Hawkins (drummer), Georgetown University School of Nursing and Health Studies, Niazi, Incidence, Healthcare, Medical device, Pharmaceutical industry, Nursing, Chiropractic

Severe adverse events associated with chiropractic treatment were found to be very rare.

Key Points: 
  • Severe adverse events associated with chiropractic treatment were found to be very rare.
  • Researchers from the Chiropractic Doctors Association of Hong Kong found that two patients experienced severe adverse events during or after their chiropractic spinal manipulation.
  • The incidence of severe adverse events was 0.21 per 100,000 treatments, which suggested that such complications were reassuringly very rare.
  • "The incidence of severe adverse events was extremely low," said Dr. Eric Chun-Pu Chu, lead author and Chairman of CDAHK.

Parsus Law is Excited to Announce Youna Kim as Corporate Counsel

Retrieved on: 
Wednesday, December 21, 2022
Northwestern University Pritzker School of Law, Politics, Walsh School of Foreign Service, Private law, Master, Female, Bachelor, London School of Business and Finance, Social justice, University School, International development, Intellectual property, London, Investment, Foreign Service, Georgetown University School of Nursing and Health Studies, BIPOC, Bank, Economics

Parsus Law has hired Atty. Youna Kim as its newest corporate attorney.

Key Points: 
  • Youna Kim is bringing her extensive legal expertise to Parsus Law as the newest member of the law firm's corporate counsel team.
  • She will be working with clients on all aspects of corporate and general counsel, as well as mergers and acquisitions.
  • Kim was based in Korea for six years, where she worked at one of the country's biggest law firms.
  • Ju Park, Parsus Law is a BIPOC and female-founded law firm that specializes in corporate law, international transactions, mergers and acquisitions, business startups, intellectual property, and real estate.

Gaumard Scientific Announces First Installation of Robotic Patient Simulator with Conversational Speech, HAL® S5301, at Emory Nursing Learning Center

Retrieved on: 
Monday, November 14, 2022
Trauma, Nell Hodgson Woodruff School of Nursing, Movement, Technology, BSN, Media contacts database, Student, Emory School, Internet access, U.S. News & World Report, Industry, YouTube, Yonsei-KOICA Master's Degree Program, Emergency medical services, Education, Health, Government, Partnership, DNP, World, Intelligence, Feedback, Patient, Practitioner, Stroke, News, Georgetown University School of Nursing and Health Studies, AI, Engineering, School, No, Faculty, Doctor of Philosophy, Family, Emory, Leadership, HAL, Doctor of Nursing Practice, Certification, Speech, Emory Healthcare, ICU, CHSE, Research, Curriculum, Policy, Science, Public health, Medicine, Facebook, MD, Nursing

MIAMI and DECATUR, Ga., Oct. 14, 2022 /PRNewswire/ -- Gaumard Scientific Co., an industry leader in simulation technology for healthcare education and training, announced that HAL® S5301, the world's most advanced interdisciplinary patient simulator, has been installed at the Emory University Nell Hodgson Woodruff School of Nursing's new state-of-the-art simulation and learning center. This is the first commercial installation of HAL S5301, which has begun shipping to customers in the U.S.

Key Points: 
  • HAL S5301 is a permanent resident at the School of Nursing's Emory Nursing Learning Center , which opened to students this fall.
  • The center also offers immersive learning opportunities for licensed nurses through the Emory Nursing Experience , a partnership with Emory Healthcare .
  • "We are thrilled to announce the first installation of HAL S5301 at the Emory University Nell Hodgson Woodruff School of Nursing.
  • Our students will be even better prepared for nursing care and leadership roles because of their work with Emory HAL."

Kirsten Suto Seckler Named to PRWeek Health Influencer 30 List

Retrieved on: 
Wednesday, November 9, 2022
Digital Marketing, Communications, Social Media, Influencer, Content Marketing, Other Communications, Public Relations, Investor Relations, Georgetown University School of Nursing and Health Studies, YouTube, PR, Marketing, Health, New Jersey Hall of Fame, Leadership, Adult education, Intellectual, PRWeek, Communication, Special Olympics World Games, Special, Addiction, Board, Georgetown University School of Continuing Studies, Multimedia, ATLAS, Automotive Executive of the Year Award, Capitol Hill, North Brunswick Township High School, Special Olympics, NBC News, Grammy Awards, Public relations, Washington Women's History Consortium, Sport, Disease, Science, Awareness, Patient, Seckler, Insurance, Shatterproof Is Not a Challenge, Olympic Games, Health issues in athletics, ESPN, Pharmaceutical industry, Facebook, The 39 Clues

Kirsten Suto Seckler, chief marketing and communications officer for Shatterproof, has been named to the PRWeek Health Influencer 30 Class of 2022.

Key Points: 
  • Kirsten Suto Seckler, chief marketing and communications officer for Shatterproof, has been named to the PRWeek Health Influencer 30 Class of 2022.
  • The annual list honors inspirational leaders who are transforming healthcare communications, with honorees chosen by the PRWeek editorial board.
  • More than 40 million Americans are currently living with a substance use disorder, which is a leading cause of preventable and accidental death.
  • The outstanding PR pros on the Health Influencer 30 list are doing really important work and blazing a trail in best practice.

Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors

Retrieved on: 
Tuesday, November 1, 2022
Honda, Survival, Board of directors, Risk, IPO, California State University, Faculty, Cherokee Nation, SEC, Anhui University, Cancer, Karolinska Institute, Research, Board, RT, Tokyo Medical and Dental University, Nasdaq, University of British Columbia, Immunotherapy, National Coalition for Syrian Revolutionary and Opposition Forces, Cherokee, Lijun International Pharmaceutical (Holding) Co. Ltd., University, National Institute of General Medical Sciences, Radiation, Patient, Audit committee, National, Georgetown University School of Medicine, Ecology, Sciences Po, Georgetown University, Quality of life, Chang Gung University, Georgetown University School of Nursing and Health Studies, Moses Austin, Pharmaceutical industry, Nursing

ROCKVILLE, Md., Nov. 1, 2022 /PRNewswire/ --Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced the appointment of Dr. Bette Jacobs to its Board of Directors as an independent director.

Key Points: 
  • ROCKVILLE, Md., Nov. 1, 2022 /PRNewswire/ --Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today announced the appointment of Dr. Bette Jacobs to its Board of Directors as an independent director.
  • Dr. Jacobs will serve on the Audit Committee and the Nominating and Corporate Governance Committee.
  • A voting member of the Cherokee Nation, Dr. Jacobs has lifetime involvement in advancing equity and diversity programs.
  • "I am excited to welcome Dr. Bette Jacobs to the board at Shuttle Pharmaceuticals," Dr. Anatoly Dritschilo, Chief Executive Officer of Shuttle Pharmaceuticals, said.

Trident University International Names Dr. Patricia Rhynders Dean of College of Health and Human Services

Retrieved on: 
Friday, October 21, 2022
Trident, Education, Doctor of Philosophy, American, California State University, Public health, Human services, CHHS, Transition, University, Texas Woman's University, Student, State University of New York at Purchase, Higher, Eastern Michigan University College of Health and Human Services, Military History Matters, Higher Learning Commission, College, Dean (education), Associate, Community health, Bachelor, Trident University International, Medicine, Management, Dean, Georgetown University School of Nursing and Health Studies

CHANDLER, Ariz., Oct. 21, 2022 /PRNewswire-PRWeb/ -- Dr. Patricia Rhynders has been named Dean of Trident University International's (Trident) College of Health and Human Services (CHHS).

Key Points: 
  • Dr. Rhynders has been named Dean of Trident's College of Health and Human Services.
  • As Dean, Dr. Rhynders will be responsible for strengthening the University's commitment to academic excellence and positive student experiences in CHHS programs.
  • These initiatives include expansion and continued quality and rigor of the college's programs in public health, health administration, and homeland security.
  • Since joining Trident in 2004, Dr. Rhynders has held multiple roles, including Associate Dean, Program Director, Faculty Lead, and Associate Professor.

Alvotech Appoints Sarah Tanksley as Chief Quality Officer

Retrieved on: 
Tuesday, October 11, 2022
NASDAQ, Judgement, Regulatory affairs, Stada Arzneimittel, Respiratory disease, Georgetown University School of Medicine, DKSH, Georgetown University School of Nursing and Health Studies, MS, Regulation of tobacco by the U.S. Food and Drug Administration, Cancer, Private Securities Litigation Reform Act, Industry, Molecular biology, GLOBE, FDA, Osteoporosis, NIH, Johns Hopkins University, Goal, Biosimilar, Academy for Advanced Academics, Compliance, SEC, GMP, Patient, Partnership, Food, Teva Pharmaceuticals, COVID-19, Degenerative disease, Management, Pharmaceutical industry, Biochemistry, EU

REYKJAVIK, Iceland, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Sarah Tanksley will join its corporate leadership team as Chief Quality Officer, effective October 14.

Key Points: 
  • REYKJAVIK, Iceland, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that Sarah Tanksley will join its corporate leadership team as Chief Quality Officer, effective October 14.
  • Sarah has been actively working with Alvotech as a consultant and we are very pleased that she will join our team in this new capacity, said Mark Levick, Chief Executive Officer of Alvotech.
  • Sarah brings strong capabilities to the role of Chief Quality Officer, having excelled in regulatory agency roles as well as a respected industry practitioner.
  • Although Alvotechs forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Alvotech.

Third Generation Assumes Chair - Edmund Optics Announces Appointment of Marisa Edmund to Chair of Edmund Optics Board

Retrieved on: 
Tuesday, August 16, 2022
Senior Member, University, Photonics, Optics, Industry, GLOBE, R, OEM, Stockton University, Board, Creativity, History, Marketing, Chairperson, Strategic planning, List of life sciences, Business studies, Ordnance Factory Board, International Society, McDonough School of Business, Culture, Empowerment, Georgetown University School of Nursing and Health Studies, Defense, SPIE, Catalog, BSBA, Surveying, Management, Director, Biomedicine

"I am delighted and honored to transition Chair responsibilities to Marisa," noted Robert Edmund, previous Chair of the Board of the Directors.

Key Points: 
  • "I am delighted and honored to transition Chair responsibilities to Marisa," noted Robert Edmund, previous Chair of the Board of the Directors.
  • "With her extensive experience, strong leadership qualities, and inspiring vision, Marisa is uniquely positioned to guide Edmund Optics into the future.
  • Marisa will continue to serve as Chief Sales and Marketing Officer for Edmund Optics, taking the lead in expanding Edmund Optics' global sales presence, partnerships, and customer collaboration.
  • Edmund Optics has been family owned and private for 80 years - that legacy will now continue with the appointment of Marisa Edmund as Chair of the Board.

FINN's Fern Lazar to Lead the FINN Global Health Practice in its Continued Growth

Retrieved on: 
Monday, February 28, 2022
Health, Partnership, Physician, Twitter, Georgetown University, Public relations, Language, Industry, Clinical trial, Philosophy, Bashe, Practice, Georgetown University School of Nursing and Health Studies, School, Instagram, MBA, Patient, Foreign Service, COVID, JD, Goal, CEO, International economics, Communication, Medical device, Medicine

NEW YORK, Feb. 28, 2022 /PRNewswire/ -- FINN Partners today promotes Fern Lazar, MBA, to managing partner, Global Health Practice Leader.

Key Points: 
  • NEW YORK, Feb. 28, 2022 /PRNewswire/ -- FINN Partners today promotes Fern Lazar, MBA, to managing partner, Global Health Practice Leader.
  • In her new position, Lazar leads more than 200 health communication professionals across 19 of FINN's 27 global offices.
  • As before, Lazar reports to Gil Bashe, managing partner, Chair Global Health and Purpose at FINN.
  • "It is a privilege to be called upon to lead one of the communication industry's foremost health practices," said Lazar.

Evernorth Names New Chief Medical Officer for Express Scripts

Retrieved on: 
Monday, November 22, 2021
Health, Pharmacy, Bright Health, Intelligence, University of Colorado School of Medicine, Forest Law Enforcement and Governance Program, University, Solution, Family, Express, Research, Professional, Public health, Express Scripts, Georgetown University School of Nursing and Health Studies, Accredo, Internal medicine, FACP, PBM, Growth, Cigna, Georgetown University School of Medicine, Management

ST. LOUIS, Nov. 22, 2021 /PRNewswire/ --Evernorth today named Christine Gilroy, MD, MSPH, FACP as chief medical officerof Express Scripts, the leading pharmacy benefit manager serving more than one in three Americans.

Key Points: 
  • ST. LOUIS, Nov. 22, 2021 /PRNewswire/ --Evernorth today named Christine Gilroy, MD, MSPH, FACP as chief medical officerof Express Scripts, the leading pharmacy benefit manager serving more than one in three Americans.
  • She will also serve as a strategic adviser and close partner to Express Scripts clients, providing guidance on critical plan design decisions.
  • Dr. Gilroy brings more than 25 years of clinical experience to Express Scripts and served most recently as associate chief medical officer of Bright Health.
  • Express Scripts is part of Evernorth Health, Cigna Corporation's health services business.